Key result
Global heart transplants exceed 7,000 annually, with ~90% concentrated in the US and Western Europe.
Answers are grounded in this paper and cite their sources.
There are profound global disparities in heart transplant access, with 90% of procedures performed in the US and Western Europe, driven by sociocultural, economic, and organ supply limitations.
Heart failure is a global disease with significant morbidity. Heart transplant (HT) can be a lifesaving therapy for select patients with end-stage heart failure. In 2020, over 7000 HTs were performed globally; 90% of HTs were performed in the United States and Western Europe, with only 10% throughout the rest of the world. In this article, we offer an overview of the global landscape of HT, exploring challenges and prospects worldwide. We review HT practices, rates and post-HT outcomes, underscoring the differences between countries within each region. We review limitations hindering HT expansion, such as sociocultural factors, as seen in Japan and Israel; health care funding, in countries like India and South Africa; socioeconomic disparities in access, like the United States; and shortage in organ supply, as seen in China and Saudi Arabia. This review underscores the need to address limitations and highlights opportunities to enhance global HT accessibility, especially in lower- and middle-income countries.
No takes yet. Share an insight, caveat, or question.
Rafei et al. (2025) conducted a review in End-stage heart failure. Heart transplant was evaluated. Heart transplant was performed over 7000 times globally in 2020, with 90% of procedures occurring in the United States and Western Europe.
Synapse has enriched 10 related papers. Consider them for comparative context: